Zirconium Cyclosilicate Lowers High Potassium Levels Associated With Potentially Lethal Cardiac Arrhythmias
Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the safety and efficacy of the drug zirconium cyclosilicate in hyperkalemia (higher than normal potassium levels) patients.